Search Menu

Archives

Higher intracellular concentrations with tenofovir alafenamide (TAF) overcomes K65R and other key NRTI resistance in vitro

Resistance data suggest important clinical benefits for patients with resistance to existing NRTIs including tenofovir.

May/June HTB now online

Coverage of the PK workshop in Amsterdam and further reports from CROI 2103: PMTCT, cardiovascular studies, new HCV drugs and more… plus treatment access including expected new WHO guidelines and Novartis case in India

Introduction to combination therapy (April 2013)

Read this guide online Order a free printed copy Download PDF 800 Kb This guide includes information about the most important aspects of HIV treatment. It is written and reviewed by HIV-positive treatment people and uses everyday language to explain medical …

DEXA

DEXA – a non-invasive scan that can measure the percentage of different body areas (whole body, trunk, right leg etc) that are muscle or fat. DEXA scans cannot determine if this is central fat (visceral adipose tissue, VAT) or sub-cutaneous …

March/April HTB online

Our first 18 reports from CROI, ARV news, a review of “When to Start Treatment?”, new US guidelines and publication reviews…

Introduction to Combination Therapy (2013)

Two of the most widely used treatment guides have been updated. Read online or order print copies…

The importance of evidence for “When to Start”: a response to Dr Myron Cohen

Simon Collins, HIV i-Base This article is prompted by approaches to the debate about when to start HIV treatment, which avoid both the complexity and lack of evidence to inform this key issue for HIV positive people, doctors and health …

Changing treatment and drug resistance (February 2013)

Read this guide online Order a free printed copy Download PDF This guide looks at what to do if your viral load rebounds and how to know whether this means that your has failed. It looks at why treatment can …

January/February HTB online

The first issue of 2013 covers women’s health, global access, paediatric TB, smoking, bone health and more besides…

Updated and revised i-Base guides

Two i-Base guides updated and reprinted for 2013: the Guide to Changing Treatment and the Guide to HIV Testing and Sexual Transmission. Order print copies online.

West Balkans edition of HTB: Issue 2 online

HIV Bilten is an HIV treatment and research information resource for the West Balkans, produced by Q Club, the Serbian association of people living with HIV.

Sample workshop course structure

These pages outline a recent course that i-Base ran for Positively UK. The numbered buttons at the bottom of the page link to each of the five sessions. Session 1: Introduction to HIV treatment and setting course priorities Topics discussed: …

November/December HTB online

News from the Glasgow Conference and the US Liver Meeting (AASLD), plus more on dolutegravir, Quad, and the importance of moving globally from use of d4T.

AIDS 2012: Noticias de la XIX Conferencia Internacional sobre el Sida

Este suplemento es una revisión no técnica de la conferencia de la IAS celebrada en Washington DC.
Traducción al español realizada por el gTt, Barcelona.

Take control of your treatment…

Stay on target with i-Base treatment guides

Bulgarian translations: two new editions of i-Base guides

Please click title link for the download page.

replicate

replicate – to duplicate, copy or reproduce. It is more scientifically accurate to refer to a virus replicating than reproducing.

escape mutation

escape mutation – a mutation or change in the genetic structure of HIV that makes it easier to evade the persons immune system (rather than a mutation that stops an HIV drug from working).

Compassionate use

Compassionate use programmes enable people with life-threatening, long-lasting or seriously disabling illnesses to use drugs that have not yet been authorised. This is usually only for drugs that are near to drug approval, especially for people who would be excluded …

September/October HTB online

News from ICAAC, further reports from IAS 2012, new BHIVA standards and Quad approval in the US.

Post navigation